NLRP3 and type 2 diabetes mellitus: NLRP3 inflammasome activation can finally result in chronic inflammation-associated diseases, such as insulin resistance, type-2 diabetes, obesity, and cancer etc. NLRP3 inflammasome may be a potentially important target for anti-inflammatory therapies [27].